Information Journal Paper
APA:
Copy. (2017). Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, 102(8), 2873-2880. SID. https://sid.ir/paper/738032/en
Vancouver:
Copy. Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?. JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM[Internet]. 2017;102(8):2873-2880. Available from: https://sid.ir/paper/738032/en
IEEE:
Copy, “Can Non-HLA Single Nucleotide Polymorphisms Help Stratify Risk in TrialNet Relatives at Risk for Type 1 Diabetes?,” JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM, vol. 102, no. 8, pp. 2873–2880, 2017, [Online]. Available: https://sid.ir/paper/738032/en